Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Optimizing RSV diagnosis by improving RSV detection in patients admitted to ED/hospitalized due to respiratory symptoms
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Vaccines Austria, Belgium, Bulgaria, Czech Republic, Finland, Greece, Ireland, Israel, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Sweden, Switzerland
    Investigating the Benefit of Early Treatment with Ritlecitinib in Alopecia Areata: A Real-World Evidence Approach
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology USA
    Guideline Concordant Care and Emerging Data for Patients with MIBC through la/mUC
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology USA
    Advancing Genomic Competence and Patient Centered Care in Metastatic Breast Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Canada, China, France, Germany, India, Italy, Japan, Spain, United Kingdom
    AI-Enabled Models for Timely COVID-19 Treatment with Nirmatrelvir/Ritonavir: Eligibility & Drug–Drug Interaction Management
    Release Date:
    Review Process: Pfizer Internal
    Research Internal Medicine Australia, Canada, Germany, Greece, Japan, Korea, Taiwan
    Clinical Data Updates on Long Term Outcomes and Practical Therapy Management Strategies in First-line ALK-posit
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology United States Minor Outlying I
    OPTIMA-HEMA Project: Optimizing the Management and Application of Novel Immunotherapies in Hematologic Malignancies
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology China
    Advancing Adult Immunization Strategies:A Focus on the Impact of Respiratory Syncytial Virus(RSV) and Cardiorespiratory Outcome
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Implementing Shared Decision Making in Hemophilia Patient Care
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Advances in Atopic Dermatitis for Dermatologists and Allergists
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Geriatric Anorexia – Educational Needs Assessment
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    2021/2022 Global Cachexia ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    Closing Knowledge Gaps in Moderate-to-Severe Atopic Dermatitis for Allergists
    Release Date:
    Partner: American College of Allergy, Asthma & Immunology (ACAAI)
    Review Process: Expert Review Panel
    Education Inflammation & Immunology USA
    Emerging Therapies for Atopic Dermatitis and Alopecia Areata for Advanced Practice Providers and Primary Care Physicians
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
    Pediatric Growth Hormone Deficiency Education
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    2021 I&I RE-CUP-IT REal world data Competitive grant in Ulcerative colitis Program - ITalian experiences
    Release Date:
    Review Process: Expert Review Panel
    Research Inflammation & Immunology Italy
    Multidisciplinary Gene Therapy Education - Recombinant Adeno-Associated Virus (rAAV)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease All
    Antimicrobial Stewardship (AMS) Programs in USA, Europe, Japan, South Korea, Australia and New Zealand
    Release Date:
    Partner: Global Bridges at Mayo Clinic
    Review Process: Expert Review Panel
    Quality Improvement Hospital All
    Cardiac Amyloidosis Mentor mATTch pRogram
    Release Date:
    Partner: Amyloidosis Foundation
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Assessing Gaps in BRAF Testing in Melanoma & Colorectal Cancer in Developing Regions
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Algeria, Argentina, Brazil, Colombia, Iraq, Kuwait, Lebanon, Mexico, Qatar, Saudi Arabia, United Arab Emirates
    Astellas and Pfizer Call for Independent Medical Education Grant Applications Oncology – Prostate Cancer
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology USA